Isbn: 9783319364438 - the prostate cancer dilemma: selecting patients for active surveillance, focal ablation and definitive therapy (9 risultati)

Perfeziona la tua ricerca

  • Libri (9)

a

Fascia di prezzo personalizzata (EUR)

a

    • Lingua: Inglese

      Editore: Springer International Publishing, 2016

      331936443X / 9783319364438

      • Brossura

      Da: moluna, Greven, Germaniamoluna

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 72,89

      EUR 48,99 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: Più di 20 disponibili

      Condizione: New.

    • Lingua: Inglese

      Editore: Springer, 2016

      331936443X / 9783319364438

      • Brossura

      Da: preigu, Osnabrück, Germaniapreigu

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 77,35

      EUR 70,00 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 5 disponibili

      Taschenbuch. Condizione: Neu. The Prostate Cancer Dilemma | Selecting Patients for Active Surveillance, Focal Ablation and Definitive Therapy | Nelson N. Stone (u. a.) | Taschenbuch | xiv | Englisch | 2016 | Springer | EAN 9783319364438 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

    • Lingua: Inglese

      Editore: Springer, 2016

      331936443X / 9783319364438

      • Brossura

      Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 120,90

      EUR 30,50 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 1 disponibili

      Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This text provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in early prostate cancer. The book reviews new data about genetic markers, transperineal mapping biopsy and mpMRI, how to apply each of these technologies in patients with elevated PSA, when a prior prostate biopsy performed by the standard TRUS method is negative and in cases where low risk disease is already diagnosed, how to differentiate those men who might harbor more aggressive disease from those who do not. Over 75% of newly diagnosed prostate cancer meets the criteria for low risk disease which has created a dilemma for both patients and clinicians. Active surveillance programs have been initiated and are reviewed. How the new technologies impact surveillance programs is addressed. Clinical stage designation is updated and a new intra-prostatic staging system is discussed. Prostate biopsy techniques utilizing transrectal ultrasound, transperineal mapping, elastography and mpMRI are compared. Finally, utilization of this new technology in the application of focal therapy is reviewed.The Prostate Cancer Dilemma will serve as a very useful resource for physicians and researchers dealing with, and interested in this challenging malignancy. Chapters are written by experts in their fields and include the most up to date scientific and clinical information as well as links to procedural video content.

    • Lingua: Inglese

      Editore: Springer, 2016

      331936443X / 9783319364438

      • Brossura

      Da: Revaluation Books, Exeter, Regno UnitoRevaluation Books

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 139,76

      EUR 34,91 spedizione 
      Spedito da Regno Unito a U.S.A.

      Quantità: 1 disponibili

      Paperback. Condizione: Brand New. reprint edition. 220 pages. 9.25x6.10x0.52 inches. In Stock.

    • Lingua: Inglese

      Editore: Springer, 2016

      331936443X / 9783319364438

      • Brossura

      Da: Books Puddle, New York, NY, U.S.A.Books Puddle

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 179,67

      EUR 3,44 spedizione 
      Spedito in U.S.A.

      Quantità: 4 disponibili

      Condizione: New. pp. 220.

    • Lingua: Inglese

      Editore: Springer, 2016

      331936443X / 9783319364438

      • Brossura

      Da: Mispah books, Redhill, SURRE, Regno UnitoMispah books

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Usato - Come nuovo

      EUR 201,35

      EUR 29,09 spedizione 
      Spedito da Regno Unito a U.S.A.

      Quantità: 1 disponibili

      Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

    • Lingua: Inglese

      Editore: Springer, 2016

      331936443X / 9783319364438

      • Brossura
      • Print on Demand

      Da: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 70,24

      EUR 24,20 spedizione 
      Spedito da Italia a U.S.A.

      Quantità: Più di 20 disponibili

      Condizione: new. Questo è un articolo print on demand.

    • Lingua: Inglese

      Editore: Springer International Publishing Okt 2016, 2016

      331936443X / 9783319364438

      • Brossura
      • Print on Demand

      Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 85,59

      EUR 23,00 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 2 disponibili

      Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This text provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in early prostate cancer. The book reviews new data about genetic markers, transperineal mapping biopsy and mpMRI, how to apply each of these technologies in patients with elevated PSA, when a prior prostate biopsy performed by the standard TRUS method is negative and in cases where low risk disease is already diagnosed, how to differentiate those men who might harbor more aggressive disease from those who do not. Over 75% of newly diagnosed prostate cancer meets the criteria for low risk disease which has created a dilemma for both patients and clinicians. Active surveillance programs have been initiated and are reviewed. How the new technologies impact surveillance programs is addressed. Clinical stage designation is updated and a new intra-prostatic staging system is discussed. Prostate biopsy techniques utilizing transrectal ultrasound, transperineal mapping, elastography and mpMRI are compared. Finally, utilization of this new technology in the application of focal therapy is reviewed.The Prostate Cancer Dilemma will serve as a very useful resource for physicians and researchers dealing with, and interested in this challenging malignancy. Chapters are written by experts in their fields and include the most up to date scientific and clinical information as well as links to procedural video content. 220 pp. Englisch.

    • Lingua: Inglese

      Editore: Springer, Springer Okt 2016, 2016

      331936443X / 9783319364438

      • Brossura
      • Print on Demand

      Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 85,59

      EUR 60,00 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 1 disponibili

      Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This text provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in early prostate cancer.The book reviews new data about genetic markers, transperineal mapping biopsy and mpMRI, how to apply each of these technologies in patients with elevated PSA, when a prior prostate biopsy performed by the standard TRUS method is negative and in cases where low risk disease is already diagnosed, how to differentiate those men who might harbor more aggressive disease from those who do not. Over 75% of newly diagnosed prostate cancer meets the criteria for low risk disease which has created a dilemma for both patients and clinicians. Active surveillance programs have been initiated andare reviewed. How the new technologies impact surveillance programsis addressed. Clinical stage designationis updated and a new intra-prostatic staging systemis discussed. Prostate biopsy techniques utilizing transrectal ultrasound, transperineal mapping, elastography and mpMRIare compared. Finally, utilization of this new technology in the application of focal therapyis reviewed.The Prostate Cancer Dilemma will serve as a very useful resource for physicians and researchers dealing with, and interested in this challenging malignancy.Chaptersare written by experts in their fields and include the most up to date scientific and clinical information as well as links to procedural videocontent.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 220 pp. Englisch.